Dye-free, multimodal, quantitative imaging to assess bowel perfusion during laparoscopic colorectal resection
Award amount
$256,579Program and phase
STTR · Phase IAward year
2021Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- OPTOSURGICAL LLC
- Proposal award date
- 2021-09-01
- Contract end date
- 2022-08-31
- UEI
- N5FFBMLQHAJ9
- Solicitation number
- PA20-265
- Topic code
- 300
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- ARPA-H PHASE II SBIR AWARD, TOPIC 03 - ROBOTICS FOR AUTONOMOUS SOFT TISSUE SURGERY TITLE: ADVANCED IMAGING AIDED AUTONOMOUS ROBOTIC CHOLECYSTECTOMY
- ARPA-H SBIR PHASE II TOPIC 4 FOR INTRA-OPERATIVE CONTRAST AGENTS
- hANDY-i(TM): A non-invasive, dual-sensor handheld imager for intraoperative preservation of parathyroid glands
- A Biliary Tract-Specific Fluorescence Image-guided Surgery
- hANDY-i(TM): A non-invasive, dual-sensor handheld imager for intraoperative preservation of parathyroid glands
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- A platform for T-cell receptor mimic antibody generation modeled using pHLA-A*11:01 KRAS G12D
- Combinatorial pipeline for discovery of anti-GPCR Nanobodies
- Development of a GBP-based glycosylation analysis system
- Extended-release injectable gel for multi-day treatment of postoperative pain
- eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening
Research funding history
6 SBIR/STTR records share this UEI (2020–2023). Reported award amounts total $9,481,151. Reported amounts are not federal obligations.
Phases: Phase I, Phase II – Direct to Phase II, Phase II
Agencies: Department of Health and Human Services